Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthoquinone scaffold

被引:63
作者
Hadden, M. Kyle [1 ]
Hill, Stephanie A. [1 ]
Davenport, Jason [2 ]
Matts, Robert L. [2 ]
Blagg, Brian S. J. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
[2] Oklahoma State Univ, Dept Biochem & Mol Biol, NRC 246, Stillwater, OK 74078 USA
基金
美国国家卫生研究院;
关键词
Hsp90; Cancer; Naphthoquinone; MCF-7; Anti-proliferation; High-throughput screening; PROTEIN-FOLDING MACHINERY; NOVOBIOCIN ANALOGS; ASSAY; HEAT-SHOCK-PROTEIN-90; CHAPERONE; IDENTIFICATION; GELDANAMYCIN; COUMARINS; DERRUBONE; DOMAIN;
D O I
10.1016/j.bmc.2008.11.064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-throughput screening of a library of diverse molecules has identified the 1,4-naphthoquinone scaffold as a new class of Hsp90 inhibitors. The synthesis and evaluation of a rationally-designed series of analogues containing the naphthoquinone core scaffold has provided key structure-activity relationships for these compounds. The most active inhibitors exhibited potent in vitro activity with low micromolar IC50 values in anti-proliferation and Her2 degradation assays. In addition, 3g, 12, and 13a induced the degradation of oncogenic Hsp90 client proteins, a hallmark of Hsp90 inhibition. The identification of these naphthoquinones as Hsp90 inhibitors provides a new scaffold upon which improved Hsp90 inhibitors can be developed. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:634 / 640
页数:7
相关论文
共 22 条
[1]   Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90 - Evidence that coumarin antibiotics disrupt Hsp90 dimerization [J].
Allan, RK ;
Mok, D ;
Ward, BK ;
Ratajczak, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) :7161-7171
[2]   High-throughput screening for Hsp90 ATPase inhibitors [J].
Avila, C ;
Hadden, MK ;
Ma, ZQ ;
Kornilayev, BA ;
Ye, QZ ;
Blagg, BSJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (11) :3005-3008
[3]   Structure-based discovery of a new class of Hsp90 inhibitors [J].
Barril, X ;
Brough, P ;
Drysdale, M ;
Hubbard, RE ;
Massey, A ;
Surgenor, A ;
Wright, L .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (23) :5187-5191
[4]   Hsp90 inhibitors: Small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation [J].
Blagg, BSJ ;
Kerr, TA .
MEDICINAL RESEARCH REVIEWS, 2006, 26 (03) :310-338
[5]   Synthesis of neoflavones by Suzuki arylation of 4-substituted coumarins [J].
Boland, GM ;
Donnelly, DMX ;
Finet, JP ;
Rea, MD .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1996, (21) :2591-2597
[6]   Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines [J].
Burlison, Joseph A. ;
Avila, Christopher ;
Vielhauer, George ;
Lubbers, Donna J. ;
Holzbeierlein, Jeffrey ;
Blagg, Brian S. J. .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (06) :2130-2137
[7]   Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machinery [J].
Burlison, Joseph A. ;
Blagg, Brian S. J. .
ORGANIC LETTERS, 2006, 8 (21) :4855-4858
[8]   The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors [J].
Cheung, KMJ ;
Matthews, TP ;
James, K ;
Rowlands, MG ;
Boxall, KJ ;
Sharp, SY ;
Maloney, A ;
Roe, SM ;
Prodromou, C ;
Pearl, LH ;
Aherne, GW ;
McDonald, E ;
Workman, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (14) :3338-3343
[9]   Chaperones increase association of tau protein with microtubules [J].
Dou, F ;
Netzer, WJ ;
Tanemura, K ;
Li, F ;
Hartl, FU ;
Takashima, A ;
Gouras, GK ;
Greengard, P ;
Xu, HX .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (02) :721-726
[10]   High-throughput assay for the identification of Hsp90 inhibitors based on Hsp90-dependent refolding of firefly luciferase [J].
Galam, Lakshmi ;
Hadden, M. Kyle ;
Ma, Zeqiang ;
Ye, Qi-Zhuang ;
Yun, Bo-Geon ;
Blagg, Brian S. J. ;
Matts, Robert L. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (05) :1939-1946